InvestorsHub Logo
icon url

nidan7500

04/13/23 9:46 AM

#410767 RE: kevindenver #410761

Regarding MFJJ developments, while we've been waiting for our MJFF study to start the technology and science around us has moved forward in a way that will strengthen 2 upcoming Anavex trials.

First is the small PET imaging study and second the trial design of Anavex's PD study slated for Australia.

https://www.michaeljfox.org/grant/evaluation-anavex2-73-blarcamesine-participants-parkinsons-disease

https://shakeitup.org.au/new-treatment-shows-clinical-benefit-in-patients-parkinsons-disease-dementia/



This is an excellent, brief summary of what this trial is doing. We are all on the same trail to the common end point, as uncomfortable as that fact may be. Stress is a killer but, it is just life's way of punching tickets. This text description of the trial is helpful for those trying to understand what is happening and how to measure-understand the process.
icon url

frrol

04/13/23 12:11 PM

#410795 RE: kevindenver #410761

Company should be announcing start of the Parkinson's trial pretty soon. Probably when enrollment is officially opened.